FR

Thomas Meyer

This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Meyer. Retrieved from https://idiyas.com/inventor/thomas-meyer-3f38ffqa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Thomas Meyer - Innovator in Pharmaceutical Compositions for Inner Ear Disorders

Introduction

Thomas Meyer is a notable inventor based in France, recognized for his contributions to the field of pharmaceuticals. He has focused his research on developing innovative solutions for treating inner ear disorders, particularly tinnitus. His work aims to improve the quality of life for individuals suffering from these conditions.

Latest Patents

Thomas Meyer holds a patent for "Pharmaceutical Compositions for the Treatment of Inner Ear Disorders." This invention provides compositions that include a pharmaceutically active agent selected from a group consisting of an arylcycloalkyamine or a derivative, analogue, or pharmaceutically active salt thereof. Additionally, it incorporates a biocompatible polymer or a combination of biocompatible polymers. These compositions or medicaments containing these compositions may be used for the prevention and/or treatment of inner ear diseases, such as tinnitus. Notably, he currently has 0 patents.

Career Highlights

Thomas Meyer is associated with Auris Medical AG, a company dedicated to developing innovative therapies for inner ear disorders. His role at the company has allowed him to contribute significantly to advancements in pharmaceutical compositions aimed at treating these challenging conditions.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Thomas Meyer is a dedicated inventor whose work in pharmaceutical compositions has the potential to transform the treatment of inner ear disorders. His innovative approach and commitment to research are commendable and highlight the importance of continued advancements in this field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…